Finance

Beta
Lists
7ZT:FRA
Hamlet BioPharma AB
€0.65
+4.50%
(+0.028) 1D
Jul 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7ZT...
Open
€0.66
High
€0.66
Low
€0.65
Avg. vol.
169.00
Volume
0.00
52-wk high
€0.83
52-wk low
€0.34
No. of employees
7
Open
€0.66
High
€0.66
Low
€0.65
Avg. vol.
169.00
Volume
0.00
52-wk high
€0.83
52-wk low
€0.34
No. of employees
7
News stories
From sources across the web
About Hamlet BioPharma AB
CEOMartin Erixon | Mats Persson
Employees7
Founded2015
Headquarters-
SectorBiotechnology
Websitehamletbiopharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
52.93K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.16M
9.62M
13.01M
9.59M
Operating expense
17.72M
12.16M
15.58M
12.17M
Total operating expenses
17.72M
12.16M
15.58M
12.17M
Operating income
-17.72M
-12.16M
-15.58M
-12.11M
Other non operating income
-1.00
-1.00
1.00
-
EBT including unusual items
-17.50M
-12.16M
-15.43M
-12.11M
EBT excluding unusual items
-17.50M
-12.16M
-15.43M
-12.11M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
3.69K
7.87K
21.35K
23.53K
Net income
-17.50M
-12.16M
-15.43M
-12.11M
Net profit margin
-
-
-
-22,880.16%
Earnings per share
-
-
-
-
Interest and investment income
222.12K
2.41K
148.19K
2.65K
Interest expense
-
-
-
-
Net interest expenses
222.12K
2.41K
148.19K
2.65K
Depreciation and amortization charges
2.56M
2.54M
2.55M
2.55M
EBITDA
-15.16M
-9.62M
-13.03M
-9.56M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer